PURPOSE: Crohn's disease is a chronic gastrointestinal inflammatory disease with possible extraintestinal symptoms. There are predisposing genetic factors and even monogenic variants of the disorder. One of the possible genetic factors are variants of the DUOX2 gene. The protein product of the DUOX2 gene is a dual oxidase enzyme producing H2O2 in the bowel. Reduced H2O2 levels impact mucosal homeostasis and contribute to the development of inflammatory bowel disease. Thus far, only 19 patients with IBD with the DUOX2 variants have been described. METHODS: Here we present a case report of an adolescent female diagnosed at eleven years of age with IBD that was subsequently reclassified as Crohn's disease. She was treated with immunosuppressants and biological therapy but experienced additional complications. Her peripheral blood lymphocyte DNA was studied using massive parallel sequencing. Detected variants were functionally studied. RESULTS: Whole exome sequencing found two novel DUOX2 gene variants: a de novo variant c.3646C>T; p.R1216W and a maternally inherited variant c.3391G>A; p.A1131T which were initially classified as variants of unknown significance. However, follow-up functional studies demonstrated that both DUOX2 variants led to impaired H2O2 generation, which led to their reclassification to the likely pathogenic class according to the ACMG.net. Therefore, we conclude that these variants are causative for the disease. CONCLUSIONS: Identifying novel variants in patients with Crohn's disease and their families is important for precision medicine approaches and understanding of the pathogenesis of likely "monogenic" rare forms of inflammatory bowel disease.

Department of Biology and Medical Genetics 2nd Faculty of Medicine Charles University Prague and Motol University Hospital Prague Czech Republic

Department of Pediatric Hematology and Oncology 2nd Medical Faculty Childhood Leukaemia Investigation Prague Charles University and Motol University Hospital Prague Czech Republic

Department of Pediatrics 2nd Medical Faculty Charles University and University Hospital Motol Prague Czech Republic

Institute of Molecular Genetics Czech Academy of Sciences Prague Czech Republic

PRENET Laboratoře Lékařské Genetiky s r o Pardubice Czech Republic

Zobrazit více v PubMed

Ashton JJ, Ennis S, Beattie RM (2017) Early-onset paediatric inflammatory bowel disease. Lancet Child Adolesc Health 1:147–158. https://doi.org/10.1016/S2352-4642(17)30017-2 PubMed DOI

Uhlig HH, Charbit-Henrion F, Kotlarz D et al (2021) Clinical Genomics for the diagnosis of monogenic forms of inflammatory bowel disease: a position paper from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 72:456–473. https://doi.org/10.1097/MPG.0000000000003017 PubMed DOI PMC

Levine AP, Pontikos N, Schiff ER et al (2016) Genetic complexity of Crohn’s Disease in two large Ashkenazi jewish families. Gastroenterology 151:698–709. https://doi.org/10.1053/j.gastro.2016.06.040 PubMed DOI

Hayes P, Dhillon S, O’Neill K et al (2015) Defects in nicotinamide-adenine dinucleotide phosphate oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol 1:489–502. https://doi.org/10.1016/j.jcmgh.2015.06.005 PubMed DOI PMC

Parlato M, Charbit-Henrion F, Hayes P et al (2017) First Identification of Biallelic inherited DUOX2 inactivating mutations as a cause of very early onset inflammatory bowel disease. Gastroenterology 153:609–611e3. https://doi.org/10.1053/j.gastro.2016.12.053 PubMed DOI

Kyodo R, Takeuchi I, Narumi S et al (2022) Novel biallelic mutations in the DUOX2 gene underlying very early-onset inflammatory bowel disease: a case report. Clin Immunol 238:109015. https://doi.org/10.1016/j.clim.2022.109015 PubMed DOI

Grasberger H, De Deken X, Miot F et al (2007) Missense mutations of dual oxidase 2 (DUOX2) implicated in congenital hypothyroidism have impaired trafficking in cells reconstituted with DUOX2 maturation factor. Mol Endocrinol 21:1408–1421. https://doi.org/10.1210/me.2007-0018 PubMed DOI

El Hassani RA, Benfares N, Caillou B et al (2005) Dual oxidase2 is expressed all along the digestive tract. Am J Physiology-Gastrointestinal Liver Physiol 288:G933–G942. https://doi.org/10.1152/ajpgi.00198.2004 DOI

Deken XD, Wang D, Many M-C et al (2000) Cloning of two human thyroid cDNAs encoding New members of the NADPH oxidase family *. J Biol Chem 275:23227–23233. https://doi.org/10.1074/jbc.M000916200 PubMed DOI

Stenke E, Bourke B, Knaus UG (2019) NADPH oxidases in inflammatory bowel disease. In: Knaus UG, Leto TL (eds) NADPH oxidases: methods and protocols. Springer, New York, NY, pp 695–713 DOI

Grasberger H, Refetoff S (2006) Identification of the maturation factor for dual oxidase: evolution of an eukaryotic operon equivalent. J Biol Chem 281:18269–18272. https://doi.org/10.1074/jbc.C600095200 PubMed DOI

Tangye SG, Al-Herz W, Bousfiha A et al (2020) Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 40:24–64. https://doi.org/10.1007/s10875-019-00737-x PubMed DOI PMC

Liu H, Naismith JH (2008) An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol 8:91. https://doi.org/10.1186/1472-6750-8-91 PubMed DOI PMC

Rigutto S, Hoste C, Grasberger H et al (2009) Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. J Biol Chem 284:6725–6734. https://doi.org/10.1074/jbc.M806893200 PubMed DOI PMC

Morand S, Ueyama T, Tsujibe S et al (2009) Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation. FASEB J 23:1205–1218. https://doi.org/10.1096/fj.08-120006 PubMed DOI PMC

Zamproni I, Grasberger H, Cortinovis F et al (2008) Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a Novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 93:605–610. https://doi.org/10.1210/jc.2007-2020 PubMed DOI

Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Sci 17(5):405–423. https://doi.org/10.1038/gim.2015.30 DOI

Grasberger H, Magis AT, Sheng E et al (2021) DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk. J Clin Invest 131:e141676. https://doi.org/10.1172/JCI141676 PubMed DOI PMC

Lipinski S, Till A, Sina C et al (2009) DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J Cell Sci 122:3522–3530. https://doi.org/10.1242/jcs.050690 PubMed DOI

Burgueño JF, Fritsch J, González EE et al (2021) Epithelial TLR4 signaling activates DUOX2 to Induce Microbiota-Driven Tumorigenesis. Gastroenterology 160:797–808e6. https://doi.org/10.1053/j.gastro.2020.10.031 PubMed DOI